Skip to main content

India bans pioglitazone : The impact

By

Widely prescribed anti-diabetes drug pioglitazone and its combinations were banned on June 26 by Governemnt of India. Along with this, painkiller analgin and anti-depressant deanxit(Flupenthixol+Melitracen) were also banned under Section 26A of the Drugs and Cosmetics Act(1940) by ministry of health and family welfare, India.

Pioglitazone's safety : Always a concern 
Pioglitazone is an anti-diabetic drug, which has unique action on improving insulin resistance by acting on PPAR receptors. Studies have reported pioglitazone causes congestive heart failure due to fluid retention and also bladder cancer. It also causes muscle aches, headache, nausea, vomiting, loss of appetite, pain in the abdomen etc. Three years ago another drug from this family, rosiglitazone was banned in India following a decision taken in European Union. Following the reports of adverse effects, France has discontinued Pioglitazone, but USA and UK allowed restricted use of Pioglitazone with a black box warning. .

Pioglitazone ban pricks patients

Ban on pioglitazone may affect 700-crore market. The patients now don’t have much options other than to resorting to costlier insulins or gliptins. The ban is also viewed by many as a partisan decision, that is going to benefit particular companies. There is protest surrounding the ban on pioglitazone and protesters claim that it will be a burden on patients as they have to opt for expensive drugs. Some doctors also suggest that there could have been an option to use pioglitazone at lower dosage with controlled monitoring of adverse effects. It is said that Indians have more insulin resistance and pioglitazone is effective and affordable option for majority of the patients.

Pioglitazone may still persist

Three weeks after the ban sources from ministry said that it may revoke the ban for restricted use with the warning about adverse effects. The reason behind this decision is that there is no affordable alternative to this widely used drug in India. 
Labels:

Comments

Post a Comment

Popular posts from this blog

Classify Rx: privacy policy

By
  The page is used to inform app users regarding our policies with the collection, use, and disclosure of Personal Information if anyone decided to use our Service. We will not use or share your information with anyone except as described in this Privacy Policy   Information Collection and Use The app does not use third party services that may collect information used to identify you as of now.   Log Data We want to inform you that whenever you use our Service, in a case of an error in the app we may receive anonymized data and information from the appropriate platform.     Cookie Cookies are files with small amount of data that is commonly used an anonymous unique identifier. These are sent to your browser from the website that you visit and are stored on your device internal memory. This Service does not use these cookies explicitly.     Links to Other Sites   This Service may contain links to other sites. If you click o...
Post a Comment
Read more

Anatnomics: Privacy policy

By
The page is used to inform app users regarding our policies with the collection, use, and disclosure of Personal Information if anyone decided to use our Service. We will not use or share your information with anyone except as described in this Privacy Policy   Information Collection and Use The app does not use third party services that may collect information used to identify you as of now.   Log Data We want to inform you that whenever you use our Service, in a case of an error in the app we may receive anonymized data and information from the appropriate platform.     Cookie Cookies are files with small amount of data that is commonly used an anonymous unique identifier. These are sent to your browser from the website that you visit and are stored on your device internal memory. This Service does not use these cookies explicitly.   Links to Other Sites   This Service may contain links to other sites. If you click on a third-party li...
Post a Comment
Read more